Correlation Engine 2.0
Clear Search sequence regions


  • adenocarcinoma (1)
  • AMACR (5)
  • antigen tumor (1)
  • help (1)
  • humans (1)
  • in 11 (1)
  • in 5 (1)
  • in 8 (1)
  • KI 67 (4)
  • ki 67 antigen (2)
  • neoplasia (3)
  • patients (6)
  • prostate (4)
  • Sizes of these terms reflect their relevance to your search.

    The aim: To determine malignant transformation and progression ability of high grade and low grade prostate intraepithelial neoplasia with the help of immunohistochemical method. Materials and methods: The results of examination of 93 patients with PIN (50 patients with high grade PIN and 43 patients with low grade PIN) were assessed comparatively using immunohistochemical markers. Semiquantitative method was used to evaluate !"-67, #63 and AMACR tissue expression with four grades from "+" to "++++" or from 1 to 4 points: '+' - low reaction, '++' - poor reaction, '+++' - moderate reaction and '++++" - intense reaction. Results: There were statistically significant differences in immunohistochemical expression rates between HGPIN and LGPIN. Patients with HGPIN had higher Ki-67 and AMACR expression rate and lower p63 expression rate than patients with LGPIN. Intense and moderate Ki-67 expression was detected in HGPIN more often, in 24 % and 11 % respectively. Low and moderate AMACR expression was determined in HGPIN more often, in 28 % and 5 % respectively. Low and not evident p63 expression was observed in HGPIN more often, in 36 % and 8 % respectively. Conclusions: HGPIN has common morphological peculiarities with prostate adenocarcinoma. Immunohistochemical detection of Ki-67, p63 and AMACR is aimed to differentiate among patients with PIN a group of high malignant transformation risk.

    Citation

    Maksym P Melnychuk. DIAGNOSTIC UTILITY OF IMMUNOHISTOCHEMICAL EXPRESSION OF KI!67, P63 AND AMACR IN PROSTATE INTRAEPITHELIAL NEOPLASIA. Wiadomosci lekarskie (Warsaw, Poland : 1960). 2023;76(2):420-426

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 37010182

    View Full Text